This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Inventor Thomas E. Richardson: Innovating in Anticoagulation Therapies
Introduction
Thomas E. Richardson is an accomplished inventor based in Albany, NY, known for his contributions to pharmaceutical advancements. With a singular patent under his belt, Richardson has made significant strides in the field of anticoagulant therapies.
Latest Patents
His notable patent, titled "Imidazo-heterobicycles as factor Xa inhibitors," represents a breakthrough in the development of medications that inhibit blood clot formation. This innovation addresses critical health issues related to thrombosis, providing new avenues for treatment options.
Career Highlights
Thomas E. Richardson is associated with Bristol-Myers Squibb Pharmaceutical Company, a leader in the biopharmaceutical industry. His work focuses on enhancing therapeutic strategies and optimizing patient care through groundbreaking research and development.
Collaborations
In his endeavors, Richardson collaborates with talented colleagues, including Patrick Y. Lam and Charles G. Clark. Their collective expertise and synergy contribute to the innovative environment at Bristol-Myers Squibb, fostering advancements in drug discovery and development.
Conclusion
Thomas E. Richardson stands out as a remarkable inventor dedicated to improving health outcomes through his work in pharmaceuticals. His patented research and collaborations reflect a commitment to innovation, underscoring his vital role in the ongoing evolution of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile